Foxp3+CD8+ regulatory T cells: bona fide Tregs with cytotoxic function
- PMID: 40113537
- DOI: 10.1016/j.it.2025.02.010
Foxp3+CD8+ regulatory T cells: bona fide Tregs with cytotoxic function
Abstract
Various mammalian CD8+ T cell subsets with regulatory properties are either formed through a thymus-dependent mechanism or induced under various experimental protocols and referred to as CD8+ regulatory T cells (Tregs). CD8+ Tregs maintain distinct functions in the presence of CD4+ Tregs. This review focuses on the Foxp3+CD8+ Treg subset, which is typically extremely rare in unmanipulated mice and healthy humans under steady-state conditions. However, they can be induced and expanded for transplantation, autoimmune diseases, cancer, viral infections, and T cell receptor transgenic adoptive cell transfer models. Here, we summarize recent research progress related to this population, including the identification of phenotypic markers, induction determinants, and functional activities. Additionally, we discuss advances in manipulating Foxp3+CD8+ Tregs in autoimmunity and transplantation.
Keywords: CD8 regulatory T cells; cytotoxic function; induction determinants; suppressive function.
Copyright © 2025 Elsevier Ltd. All rights reserved.
Conflict of interest statement
Declaration of interests B.R.B. reports research funding from BlueRock Therapeutics and Carisma Therapeutics and consulting fees from BlueRock Therapeutics, Sandoz, Sanofi, Legend Biotech, GentiBio Inc., and Magenta Therapeutics. J.H.L. and B.R.B. have submitted a patent application for human CD8 iTreg dual suppressor and cytolytic function.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials